Results 131 to 140 of about 12,143 (160)
Some of the next articles are maybe not open access.

Ranitidine and Depression

Australian & New Zealand Journal of Psychiatry, 1991
Three cases are described in which the cessation of the H2-antagonist ranitidine was followed by a rapid improvement in severe depressive symptoms. The literature concerning H2-receptor antagonists and depression is reviewed, and an alternative drug (omeprazole) for severe peptic ulceration is discussed.
openaire   +3 more sources

Genotoxicity of nitrosated ranitidine

Carcinogenesis, 1983
The in vitro reaction of nitrite with the histamine H2-receptor antagonist ranitidine, in acidified solutions or in human gastric juice, resulted in the formation of genotoxic derivatives, mainly eliciting base-pair substitutions in his-Salmonella typhimurium and trp- Escherichia coli and inducing an increased lethality in DNA repair-deficient bacteria.
Anna Camoirano   +3 more
openaire   +2 more sources

Side Effects of Ranitidine

Drug Safety, 1991
Ranitidine was first marketed in 1981; since then many patients have been treated such that much experience has been accumulated on the safety of this histamine H2-receptor antagonist in the treatment of gastroduodenal disease. A wide array of ranitidine-associated side effects has been described, but infrequently.
Thierry Vial   +5 more
openaire   +3 more sources

The efficacy of ranitidine in children

Acta Anaesthesiologica Scandinavica, 1987
The effect of preoperative oral ranitidine on intragastric pH and volume of aspirate was evaluated in anaesthetized children. Five groups of eight randomly assigned children were evaluated. The first group acted as control and the other groups received 2, 2.5, 3, 3.5 mg kg‐1 ranitidine, respectively. The drug was administered 1–4 h preoperatively.
E. T. Young, Nishan G. Goudsouzian
openaire   +3 more sources

Hepatitis Associated with Ranitidine

Annals of Internal Medicine, 1984
Excerpt Ranitidine (Zantac; Glaxo, Incorporated, Research Triangle Park, North Carolina) is a relatively new H2-receptor antagonist with a potency fourfold to eightfold that of Cimetidine.
openaire   +4 more sources

Ranitidine and Theophylline

Annals of Internal Medicine, 1985
Excerpt To the editor: A recent report described theophylline toxicity during ranitidine administration (1). We wish to report a similar experience.
Marie E. Gardner, Gerlad W. Sikorski
openaire   +2 more sources

Ranitidine and Bradycardia

Annals of Internal Medicine, 1988
Excerpt To the editor: The histamine-2 (H2) receptor antagonist drugs (Cimetidine, ranitidine, and famotidine) are generally well tolerated.
Donald R. Miller, Walter S. Johnson
openaire   +2 more sources

Ranitidine and Acetaminophen Hepatotoxicity

Annals of Internal Medicine, 1984
Excerpt To the editor: We read with interest the recent editorial (1) comparing ranitidine and cimetidine.
Kermit V Speeg   +2 more
openaire   +3 more sources

Ranitidine-induced photosensitivity

Clinical and Experimental Dermatology, 1995
We report the case of a 72-year-old male patient who developed a florid photosensitive eruption while on ranitidine therapy. Ultraviolet A sensitivity was detected by irradiation monochromator testing, suggesting drug-induced photosensitivity. Ranitidine was concluded to be the cause of his photosensitivity since the eruption resolved and the phototest
A.W.P. Du Vivier   +3 more
openaire   +3 more sources

Possible Ranitidine Hepatotoxicity

Annals of Internal Medicine, 1984
Excerpt Ranitidine (Zantac; Glaxo Incorporated, Research Triangle Park, North Carolina) is a newly introduced H2-receptor antagonist approved by the Food and Drug Administration for short-term oral...
Robert Kanter   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy